News

Empowering Cancer Patients and their Caregivers: CSC Partners with EO Care for Clinically Guided Cannabis Support

April 24, 2024
|
The EO Team
Cancer Support Community Logo Gilda's Club logo

Cancer Support Community (CSC) has teamed up with EO Care, a leader in clinically guided cannabis health solutions, to provide cancer patients, survivors, and their caregivers with comprehensive support.

With 40% of cancer patients already turning to cannabis for symptom relief, this partnership offers CSC members access to educational materials and personalized guidance on cannabis to ensure its safe and effective use. Led by Dr. Brooke Worster, Director of Supportive Oncology at Jefferson Health and Chief Medical Officer at EO, our specialized expertise ensures that cancer patients receive accurate, personalized information and support through CSC's resources and helpline. This collaboration reflects a crucial step in empowering all those impacted by cancer to make informed decisions about their healthcare journey, providing them with the tools and support needed to navigate their treatment with confidence.

Read the full press release here.

<-  Back to blog
More
News
News

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also reported low rates of use-limiting side effects with further reductions after receiving updated recommended product and/or dosing guidance via EO Care’s digital care platform.

Read More
Read More
News

EO Launches Its Next Generation Cannabinoid Care Platform

New scalable, digital health offering makes personalized, clinically responsible cannabinoid guidance accessible to all older adults, adults in cancer treatment and cancer survivors.‍The platform was designed and tested with patients and clinicians at leading hospitals and NCI-Designated Cancer Centers.

Read More
Read More
News

Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective

Recently, the Department of Health and Human Services recommended that cannabis be reclassified from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. In a PM360 article Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective,

Read More
Read More